Ka Zhang

601 total citations
44 papers, 387 citations indexed

About

Ka Zhang is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Ka Zhang has authored 44 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 24 papers in Hepatology and 8 papers in Immunology. Recurrent topics in Ka Zhang's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). Ka Zhang is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). Ka Zhang collaborates with scholars based in China, Singapore and Canada. Ka Zhang's co-authors include Xin Shu, Aiqin Mao, Xin Ma, Hong Cao, Hao Kan, Gang Li, Lei Feng, Zhiwei Wang, Xingfei Pan and Fan Yu and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Ka Zhang

42 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ka Zhang China 13 143 135 97 73 52 44 387
Michelle Melino Australia 11 170 1.2× 161 1.2× 84 0.9× 87 1.2× 57 1.1× 16 393
Mitsuru Ohata Japan 9 241 1.7× 151 1.1× 125 1.3× 62 0.8× 54 1.0× 20 451
Jiayin Yang China 13 148 1.0× 157 1.2× 142 1.5× 47 0.6× 84 1.6× 33 476
Branimir Popovic United States 7 124 0.9× 85 0.6× 105 1.1× 48 0.7× 76 1.5× 12 319
Xiaobo Cai China 11 179 1.3× 173 1.3× 120 1.2× 51 0.7× 80 1.5× 24 377
Kim Olievier Belgium 8 134 0.9× 91 0.7× 118 1.2× 84 1.2× 45 0.9× 10 358
Ji‐Chao Zhou China 8 135 0.9× 65 0.5× 178 1.8× 58 0.8× 34 0.7× 15 381
Doris Stoll Germany 8 160 1.1× 184 1.4× 151 1.6× 108 1.5× 94 1.8× 12 508
Andreas Nellen Germany 8 177 1.2× 164 1.2× 68 0.7× 167 2.3× 49 0.9× 8 410
Zhi-bing Ou China 11 155 1.1× 49 0.4× 183 1.9× 81 1.1× 117 2.3× 12 409

Countries citing papers authored by Ka Zhang

Since Specialization
Citations

This map shows the geographic impact of Ka Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka Zhang more than expected).

Fields of papers citing papers by Ka Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka Zhang. The network helps show where Ka Zhang may publish in the future.

Co-authorship network of co-authors of Ka Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Ka Zhang. A scholar is included among the top collaborators of Ka Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka Zhang. Ka Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kan, Hao, Liu Yang, Zhiwei Wang, et al.. (2025). Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice. Aging Cell. 24(5). e14469–e14469. 1 indexed citations
2.
Zhu, Yuxin, Hao Kan, Aiqin Mao, et al.. (2024). Single-cell transcriptome analysis reveals status changes of immune cells in chronic kidney disease. Frontiers in Medicine. 11. 1434535–1434535. 1 indexed citations
3.
Zhang, Ka, et al.. (2023). Genetics in Ischemic Stroke: Current Perspectives and Future Directions. Journal of Cardiovascular Development and Disease. 10(12). 495–495. 8 indexed citations
4.
5.
Zhu, Yifei, Sheng Wang, Yuan Chu, et al.. (2022). TRPC5 is essential in endothelium-dependent contraction of aorta from diet-induced obese mice. Fundamental Research. 2(3). 429–436.
6.
Shu, Xin, et al.. (2021). Correlation of effective hepatic blood flow with liver pathology in patients with hepatitis B virus. Liver Research. 5(4). 243–250. 4 indexed citations
7.
Jia, Yifan, Xin Shu, Huijuan Cao, et al.. (2020). Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis. Stem Cell Research & Therapy. 11(1). 277–277. 30 indexed citations
8.
Shao, Jing, Jing Han, Yifei Zhu, et al.. (2019). Curcumin Induces Endothelium-Dependent Relaxation by Activating Endothelial TRPV4 Channels. Journal of Cardiovascular Translational Research. 12(6). 600–607. 14 indexed citations
9.
Pan, Xingfei, Hong Cao, Xin Shu, et al.. (2017). IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs. Experimental and Therapeutic Medicine. 14(4). 3880–3886. 7 indexed citations
10.
Zhang, Ka, et al.. (2017). Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs. Scientific Reports. 7(1). 13383–13383. 18 indexed citations
11.
Zhang, Ka, et al.. (2016). CONSORT. Medicine. 95(31). e4471–e4471. 12 indexed citations
12.
Zhang, Ka. (2015). The Symptoms Types in Soybean Leaves Caused by Soybean Mosaic Virus. Dadou kexue. 1 indexed citations
13.
14.
Jie, Yusheng, et al.. (2014). Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute-on-chronic liver failure. International Journal of Infectious Diseases. 22. 78–82. 1 indexed citations
15.
Zhang, Ka. (2013). Analysis of Factors Making Antituberculosis Drugs Affect Liver Function of Patients with Pulmonary Tuberculosis. 1 indexed citations
16.
Pan, Xingfei, Ka Zhang, Xuejun Li, et al.. (2013). Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients. PLoS ONE. 8(7). e68568–e68568. 21 indexed citations
17.
Zhang, Ka. (2013). Logistic Regression Analysis for the Risk Factors of Chronic Obstructive Pulmonary Diseases. 1 indexed citations
18.
Zhang, Ka, Xingfei Pan, Xin Shu, et al.. (2013). Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cellular Immunology. 282(2). 113–116. 13 indexed citations
19.
Pan, Xingfei, Xin Shu, Hong Cao, et al.. (2012). Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. Journal of Infection. 65(4). 336–342. 30 indexed citations
20.
Zhang, Ka, et al.. (2011). [Comparative study on the clinical characteristics of HBV/HCV co-infection patients with different HCV contaminnation mode].. PubMed. 25(4). 301–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Melino Breakdown of academic impact, for papers by Mitsuru Ohata Breakdown of academic impact, for papers by Jiayin Yang Breakdown of academic impact, for papers by Branimir Popovic Breakdown of academic impact, for papers by Xiaobo Cai Breakdown of academic impact, for papers by Kim Olievier Breakdown of academic impact, for papers by Ji‐Chao Zhou Breakdown of academic impact, for papers by Doris Stoll Breakdown of academic impact, for papers by Andreas Nellen Breakdown of academic impact, for papers by Zhi-bing Ou
Rankless by CCL
2026